These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35879412)

  • 1. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.
    Biering SB; Sarnik SA; Wang E; Zengel JR; Leist SR; Schäfer A; Sathyan V; Hawkins P; Okuda K; Tau C; Jangid AR; Duffy CV; Wei J; Gilmore RC; Alfajaro MM; Strine MS; Nguyenla X; Van Dis E; Catamura C; Yamashiro LH; Belk JA; Begeman A; Stark JC; Shon DJ; Fox DM; Ezzatpour S; Huang E; Olegario N; Rustagi A; Volmer AS; Livraghi-Butrico A; Wehri E; Behringer RR; Cheon DJ; Schaletzky J; Aguilar HC; Puschnik AS; Button B; Pinsky BA; Blish CA; Baric RS; O'Neal WK; Bertozzi CR; Wilen CB; Boucher RC; Carette JE; Stanley SA; Harris E; Konermann S; Hsu PD
    Nat Genet; 2022 Aug; 54(8):1078-1089. PubMed ID: 35879412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.
    Rebendenne A; Roy P; Bonaventure B; Chaves Valadão AL; Desmarets L; Arnaud-Arnould M; Rouillé Y; Tauziet M; Giovannini D; Touhami J; Lee Y; DeWeirdt P; Hegde M; Urbach S; Koulali KE; de Gracia FG; McKellar J; Dubuisson J; Wencker M; Belouzard S; Moncorgé O; Doench JG; Goujon C
    Nat Genet; 2022 Aug; 54(8):1090-1102. PubMed ID: 35879413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
    Wang R; Simoneau CR; Kulsuptrakul J; Bouhaddou M; Travisano KA; Hayashi JM; Carlson-Stevermer J; Zengel JR; Richards CM; Fozouni P; Oki J; Rodriguez L; Joehnk B; Walcott K; Holden K; Sil A; Carette JE; Krogan NJ; Ott M; Puschnik AS
    Cell; 2021 Jan; 184(1):106-119.e14. PubMed ID: 33333024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
    Wei J; Alfajaro MM; DeWeirdt PC; Hanna RE; Lu-Culligan WJ; Cai WL; Strine MS; Zhang SM; Graziano VR; Schmitz CO; Chen JS; Mankowski MC; Filler RB; Ravindra NG; Gasque V; de Miguel FJ; Patil A; Chen H; Oguntuyo KY; Abriola L; Surovtseva YV; Orchard RC; Lee B; Lindenbach BD; Politi K; van Dijk D; Kadoch C; Simon MD; Yan Q; Doench JG; Wilen CB
    Cell; 2021 Jan; 184(1):76-91.e13. PubMed ID: 33147444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-scale CRISPR screens identify host factors that promote human coronavirus infection.
    Grodzki M; Bluhm AP; Schaefer M; Tagmount A; Russo M; Sobh A; Rafiee R; Vulpe CD; Karst SM; Norris MH
    Genome Med; 2022 Jan; 14(1):10. PubMed ID: 35086559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2.
    Israeli M; Finkel Y; Yahalom-Ronen Y; Paran N; Chitlaru T; Israeli O; Cohen-Gihon I; Aftalion M; Falach R; Rotem S; Elia U; Nemet I; Kliker L; Mandelboim M; Beth-Din A; Israely T; Cohen O; Stern-Ginossar N; Bercovich-Kinori A
    Nat Commun; 2022 Apr; 13(1):2237. PubMed ID: 35469023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host-virus interaction studies.
    Tang WF; Tran AT; Wang LY; Horng JT
    Biomed J; 2023 Apr; 46(2):100587. PubMed ID: 36849044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses.
    Rebendenne A; Roy P; Bonaventure B; Chaves Valadão AL; Desmarets L; Rouillé Y; Tauziet M; Arnaud-Arnould M; Giovannini D; Lee Y; DeWeirdt P; Hegde M; Garcia de Gracia F; McKellar J; Wencker M; Dubuisson J; Belouzard S; Moncorgé O; Doench JG; Goujon C
    bioRxiv; 2021 May; ():. PubMed ID: 34031654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome CRISPR screening strategy to identify genes contributing to SARS-CoV-2 spike and VSV-G mediated entry.
    Hossain MS; Kerkvliet JG; Hoppe AD
    J Med Virol; 2023 Sep; 95(9):e29087. PubMed ID: 37707319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.
    Rebendenne A; Roy P; Bonaventure B; Chaves VAL; Desmarets L; Rouillé Y; Tauziet M; Arnaud-Arnould M; Giovannini D; Lee Y; DeWeirdt P; Hegde M; Garcia de GF; McKellar J; Wencker M; Dubuisson J; Belouzard S; Moncorgé O; Doench JG; Goujon C
    Res Sq; 2021 May; ():. PubMed ID: 34075371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
    Schneider WM; Luna JM; Hoffmann HH; Sánchez-Rivera FJ; Leal AA; Ashbrook AW; Le Pen J; Ricardo-Lax I; Michailidis E; Peace A; Stenzel AF; Lowe SW; MacDonald MR; Rice CM; Poirier JT
    Cell; 2021 Jan; 184(1):120-132.e14. PubMed ID: 33382968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry.
    Zhu S; Liu Y; Zhou Z; Zhang Z; Xiao X; Liu Z; Chen A; Dong X; Tian F; Chen S; Xu Y; Wang C; Li Q; Niu X; Pan Q; Du S; Xiao J; Wang J; Wei W
    Sci China Life Sci; 2022 Apr; 65(4):701-717. PubMed ID: 34431042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2.
    Baggen J; Persoons L; Vanstreels E; Jansen S; Van Looveren D; Boeckx B; Geudens V; De Man J; Jochmans D; Wauters J; Wauters E; Vanaudenaerde BM; Lambrechts D; Neyts J; Dallmeier K; Thibaut HJ; Jacquemyn M; Maes P; Daelemans D
    Nat Genet; 2021 Apr; 53(4):435-444. PubMed ID: 33686287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
    Corley MJ; Pang APS; Dody K; Mudd PA; Patterson BK; Seethamraju H; Bram Y; Peluso MJ; Torres L; Iyer NS; Premeaux TA; Yeung ST; Chandar V; Borczuk A; Schwartz RE; Henrich TJ; Deeks SG; Sacha JB; Ndhlovu LC
    J Leukoc Biol; 2021 Jul; 110(1):21-26. PubMed ID: 33464637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
    Daniloski Z; Jordan TX; Wessels HH; Hoagland DA; Kasela S; Legut M; Maniatis S; Mimitou EP; Lu L; Geller E; Danziger O; Rosenberg BR; Phatnani H; Smibert P; Lappalainen T; tenOever BR; Sanjana NE
    Cell; 2021 Jan; 184(1):92-105.e16. PubMed ID: 33147445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.
    Behura A; Naik L; Patel S; Das M; Kumar A; Mishra A; Nayak DK; Manna D; Mishra A; Dhiman R
    Biochim Biophys Acta Mol Basis Dis; 2023 Mar; 1869(3):166634. PubMed ID: 36577469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cell type specific ACE2 modifiers by CRISPR screening.
    Sherman EJ; Mirabelli C; Tang VT; Khan TG; Leix K; Kennedy AA; Graham SE; Willer CJ; Tai AW; Sexton JZ; Wobus CE; Emmer BT
    PLoS Pathog; 2022 Mar; 18(3):e1010377. PubMed ID: 35231079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.